Leucodepletion and blood products

Background: Leucoreduction of blood products is increasingly being employed to produce blood products with residual WBCs < 5 × 10 6 per unit (99.9 percent or a log 3 leucoreduction). Clinical data suggests that non-haemolytic febrile transfusion reactions can be prevented by leucodepletion. The p...

Full description

Saved in:
Bibliographic Details
Published in:Medical journal. Armed Forces India 2006-04, Vol.62 (2), p.174-177
Main Authors: Kumar, Harsh, Gupta, PK, Mishra, DK, Sarkar, RS, Jaiprakash, M
Format: Article
Language:English
Subjects:
alloimmunisation
Contemporary Issue
leucodepletion
Leucoreduction
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Leucoreduction of blood products is increasingly being employed to produce blood products with residual WBCs < 5 × 10 6 per unit (99.9 percent or a log 3 leucoreduction). Clinical data suggests that non-haemolytic febrile transfusion reactions can be prevented by leucodepletion. The procedure also prevents alloimmunisation to HLA antigens in patients who will repeatedly require transfusion of blood/blood products. Method: Of the methods available to reduce the number of WBC in blood products washing of red cells, freezing and deglycerolisation are effective and yield a product with only a 24 hour shelf life. Other methods such as leucodepletion filters are relatively inexpensive, simple and the final product has a normal shelf life. Modern generation of leucoreduction filters and apheresis machines can provide greater than 4 log reduction of WBC. Results: After the introduction of leucodepletion of blood for Thalassemics at our center in 2003, the incidence of non haemolytic febrile transfusion reactions (NHFTR) fell from 4% in 2002 to 1% in 2003. Conclusion: In patients undergoing long-term blood transfusion therapy e.g. Thalassemics, alloimmunisation against the HLA antigens on donor white cells is prevented by leucodepletion and prevents NHFTRs.
ISSN:0377-1237
DOI:10.1016/S0377-1237(06)80064-X